Overview
Balance Sheet
Cash Flow
Growth Analysis
2023
2022
2021
2020
2019
Profitability Metrics
Gross Margin
48.32%
Operating Margin
24.87%
Net Margin
20.96%
Efficiency Metrics
Revenue per Expense Ratio
1.33
R&D as % of Revenue
0.00%
Earnings Quality
EBITDA Margin
39.28%
Income Tax Rate
2.16%
EPS
0.9300000000
Balance Sheet Analysis
Current Ratio
3.33
Cash Ratio
2.57
Working Capital
$385.62M
Debt to Equity
0.38
Debt to Assets
26.40%
Equity Ratio
68.80%
Cash Flow Analysis
Operating Cash Flow Ratio
20.09%
Free Cash Flow Ratio
8.93%
CapEx to Revenue
11.17%
Dividends Paid
$59.83M
Stock Buybacks
$59.75M
Total Shareholder Returns
$119.58M
Cash Position Change
214.05%
Key Takeaways (2023 FY)
Maintained positive net income growth despite revenue changes
Increased dividend payments by 149.23%
Detailed Growth Metrics
Core Performance
Revenue
8.11%
Net Income
136.81%
EPS
173.53%
Operating Income
134.47%
Operational Efficiency
R&D Expenses
-100.00%
SG&A Expenses
-73.43%
Operating Cash Flow
-5.37%
Free Cash Flow
145.19%
Balance Sheet Health
Assets
2.16%
Debt
0.51%
Book Value per Share
7.47%
Inventory
-100.00%
Shareholder Returns
Dividends per Share
149.23%
Shares Outstanding
-3.30%
Long Term Trends
3Y Revenue/Share
286.55%
5Y Revenue/Share
-6.52%
3Y Dividend/Share
-59.79%
5Y Dividend/Share
-62.99%